U.S. Senator Maggie Hassan is turning the spotlight on a national methadone clinic chain operating in New Hampshire, accusing the company of improper business practices and delivering substandard care to some of the state’s most vulnerable residents. The allegations against New Season Treatment Centers come at a time when the opioid crisis continues to claim hundreds of lives across the Granite State each year.
Hassan’s Concerns Take Shape
In a letter detailed by the New Hampshire Bulletin, Hassan laid out a series of concerns about New Season’s operations, drawing on interviews with both current employees and clients of the clinic chain. The senator’s office conducted its own review after receiving complaints about the quality and integrity of services at the company’s New Hampshire locations.
The concerns go beyond standard regulatory disagreements. Hassan’s findings suggest a pattern of practices that may be putting patients at financial and medical risk during one of the most critical phases of their recovery from opioid addiction.
The Human Cost of False Positives
Among the most striking allegations are reports of problematic drug testing practices at New Season facilities. Clients described situations in which false positive results on drug tests led to real financial consequences for people already struggling to get back on their feet.
One clinic client spoke about the burden that even seemingly small costs can impose on someone in early recovery: “That’s not a lot of money to me… but that is a devastating amount of money for somebody early in recovery.”
The remark underscores a reality that policymakers and treatment providers sometimes overlook. For individuals rebuilding their lives after addiction, unexpected fees, retesting costs, or changes to treatment plans triggered by inaccurate test results can create cascading problems that jeopardize their progress.
An Epidemic That Demands Better
Hassan framed her concerns within the broader context of a crisis that shows no signs of abating. “Drug overdoses killed nearly 79,400 Americans in 2024 — and nearly 300 New Hampshire residents,” the senator noted, emphasizing the scale of the problem and the corresponding need for treatment providers to maintain the highest standards of care.
Those numbers reflect the ongoing severity of the opioid epidemic, which has reshaped communities across New Hampshire over the past decade. From rural towns in the North Country to cities like Manchester and Nashua, few corners of the state have been untouched by addiction and its consequences.
Medication-assisted treatment, including methadone maintenance, is widely regarded by medical professionals as one of the most effective approaches to opioid addiction. However, national data suggests that only about 25 percent of Americans with opioid use disorder currently receive such treatment. That gap makes the quality and accessibility of existing providers all the more important.
New Season’s Footprint
New Season Treatment Centers operates methadone clinics across multiple states, including several locations in New Hampshire. The company is part of a broader trend of national chains expanding into the addiction treatment market, a development that has brought both increased capacity and concerns about corporate priorities in healthcare.
Critics of the for-profit treatment model argue that the pressure to generate revenue can conflict with the patient-centered approach that addiction medicine demands. Hassan’s letter appears to touch on precisely those tensions, questioning whether New Season’s business practices are aligned with the needs of the patients it serves.
What Happens Next
Hassan’s public intervention raises the stakes for both New Season and the regulatory agencies responsible for overseeing methadone clinics in New Hampshire. The senator’s letter is likely to prompt scrutiny from state health officials and could lead to formal investigations into the company’s practices.
For the thousands of Granite State residents currently receiving medication-assisted treatment, the outcome matters enormously. Access to reliable, high-quality methadone treatment can mean the difference between sustained recovery and relapse. When providers fall short, the consequences are measured not just in dollars but in lives.
The broader conversation about addiction treatment in New Hampshire continues to evolve as the state grapples with how best to support residents in recovery while holding providers accountable for the care they deliver.
